Share
Other content recommended for you
- Diagnosis and management of giant cell arteritis and polymyalgia rheumatica: challenges, controversies and practical tips
- Rapid visual recovery following intravenous tocilizumab in glucocorticoid resistant refractory giant cell arteritis
- Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis
- Efficacy and safety of tocilizumab in giant cell arteritis: a single centre NHS experience using imaging (ultrasound and PET - CT) as a diagnostic and monitoring tool
- Long - term efficacy and safety of tocilizumab in giant cell arteritis and large vessel vasculitis
- Probability - based algorithm using ultrasound and additional tests for suspected GCA in a fast - track clinic
- Stroke associated with giant cell arteritis: a population - based study
- 2018 Update of the EULAR recommendations for the management of large vessel vasculitis
- Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab - treated patients
- Giant cell arteritis manifested by chronic dry cough